BOI:EPA
Boiron SA
€18.75
arrow_upward
+0.27%(+0.050) 1D
Nov 2, 11:20:33 AM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
€18.85
High
€18.85
Low
€18.70
Mkt. cap
328.98M
Avg. vol.
5.37K
Volume
50.00
P/E ratio
12.43
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55M
No. of employees
3K
Open
€18.85
High
€18.85
Low
€18.70
Mkt. cap
328.98M
Avg. vol.
5.37K
Volume
50.00
P/E ratio
12.43
52-wk high
€32.25
52-wk low
€16.90
EPS
€1.51
Shares outstanding
17.55M
No. of employees
3K
News stories
From web sources and news partners
Business Insider
·
17 minutes ago
The S&P 500 may be headed for 'outsized gains' despite tech-stock rout, JPMorgan says
marketscreener.com
·
28 minutes ago
Gold rebounds from one-year low as oil slides ahead of US midterms
Inc.com
·
28 minutes ago
The S&P 500 Hasn’t Moved in Months, but 2 Sectors Jumped More Than 10 Percent in October
Seeking Alpha
·
31 minutes ago
Turkey month delivers: S&P 500 has climbed in 74% of Novembers
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA